Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

ClinicalTrials.gov ID: NCT00365612

Public ClinicalTrials.gov record NCT00365612. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 7:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase IV, Open-Label, Randomized, Multicenter Study Evaluating Efficacy and Tolerability of Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir DF Compared to Unmodified HAART in HIV-1 Infected Subjects Who Have Achieved Virological Suppression on Their HAART Regimen

Study identification

NCT ID
NCT00365612
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Gilead Sciences
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

  • Efavirenz (EFV), Emtricitabine (FTC), Tenofovir DF (TDF) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Sep 30, 2007
Completion
Dec 31, 2007
Last update posted
Apr 9, 2008

2006 – 2008

United States locations

U.S. sites
54
U.S. states
24
U.S. cities
53
Facility City State ZIP Site status
Not listed Hobson City Alabama 36201
Not listed Phoenix Arizona 85006
Not listed Beverly Hills California 90211
Not listed Long Beach California 90813
Not listed Los Angeles California 90069
Not listed Oakland California 94609
Not listed San Diego California 92103
Not listed San Francisco California 94114
Not listed Tarzana California 91356
Not listed Denver Colorado 80220
Not listed Norwalk Connecticut 06851
Not listed Washington D.C. District of Columbia 20037
Not listed Fort Lauderdale Florida 33308
Not listed Hollywood Florida 33020
Not listed Miami Florida 33136
Not listed Orlando Florida 32803
Not listed Pensacola Florida 32504
Not listed Port Saint Lucie Florida 34952
Not listed Safety Harbor Florida 34695
Not listed Tampa Florida 33607
Not listed Vero Beach Florida 32960
Not listed Atlanta Georgia 30312
Not listed Decatur Georgia 30033
Not listed Aurora Illinois 60505
Not listed Chicago Illinois 60657
Not listed Indianapolis Indiana 46280
Not listed Baltimore Maryland 21201
Not listed Boston Massachusetts 02030
Not listed Springfield Massachusetts 01107
Not listed Berkley Michigan 48072
Not listed Grosse Pointe Woods Michigan 48236
Not listed Minneapolis Minnesota 55404
Not listed St Louis Missouri 63139
Not listed Hillsborough New Jersey 08844
Not listed Newark New Jersey 07101
Not listed Newark New Jersey 07102
Not listed Somers Point New Jersey 08244
Not listed Albany New York 12208
Not listed Brooklyn New York 11203
Not listed Mount Vernon New York 10550
Not listed New York New York 10011
Not listed Rochester New York 14604
Not listed Charlotte North Carolina 28209
Not listed Greenville North Carolina 27858
Not listed Winston-Salem North Carolina 27157
Not listed Akron Ohio 44304
Not listed Philadelphia Pennsylvania 19107
Not listed Providence Rhode Island 02906
Not listed Dallas Texas 75204
Not listed Harlingen Texas 78550
Not listed Houston Texas 77009
Not listed Annandale Virginia 22003
Not listed Hampton Virginia 23666
Not listed Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00365612, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2008 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00365612 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →